Pilot randomized phase II study of celecoxib in oral premalignant lesions.
Papadimitrakopoulou VA, William WN Jr, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO.
Papadimitrakopoulou VA, et al. Among authors: lee jj.
Clin Cancer Res. 2008 Apr 1;14(7):2095-101. doi: 10.1158/1078-0432.CCR-07-4024.
Clin Cancer Res. 2008.
PMID: 18381950
Clinical Trial.